BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21349894)

  • 1. NHS launches legal action against makers of Gaviscon.
    Dyer C
    BMJ; 2011 Feb; 342():d1278. PubMed ID: 21349894
    [No Abstract]   [Full Text] [Related]  

  • 2. Company managed to block development of generic drug.
    Kmietowicz Z
    BMJ; 2008 Mar; 336(7644):576. PubMed ID: 18340056
    [No Abstract]   [Full Text] [Related]  

  • 3. Gaviscon maker is accused of rigging the market.
    Kmietowicz Z
    BMJ; 2010 Feb; 340():c1121. PubMed ID: 20181636
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative study of Algicon versus Gaviscon in symptomatic gastro-oesophageal reflux.
    Ward AE
    Br J Clin Pract Suppl; 1989 Feb; 66():52-5; discussion 61-4. PubMed ID: 2556176
    [No Abstract]   [Full Text] [Related]  

  • 5. [TREATMENT WITH GAVISCON IN HIATUS HERNIA. PRELIMINARY RESULTS].
    SANDMARK S; ZENK L
    Sven Lakartidn; 1964 Jun; 61():1940-3. PubMed ID: 14161878
    [No Abstract]   [Full Text] [Related]  

  • 6. Gaviscon for gastro-oesophageal reflux in infants: a poorly effective treatment?
    Cresi F; Savino F; Marinaccio C; Silvestro L
    Arch Dis Child; 2006 Jan; 91(1):93. PubMed ID: 16371388
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative intragastric pH profile of Algicon versus Gaviscon.
    Stoddard CJ; Morgan GE
    Br J Clin Pract Suppl; 1989 Feb; 66():29-34; discussion 35-6. PubMed ID: 2556174
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of gastro-esophageal reflux using a potable gaviscon suspension].
    Guerre J; Neuman M; Bouchet J
    Med Chir Dig; 1982; 11(4):289-95. PubMed ID: 6287126
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison between cisapride and Gaviscon with Carobel in the treatment of gastro-oesophageal reflux in infancy.
    Greally P; Hampton FJ; MacFadyen UM; Simpson H
    Ir Med J; 1992; 85(4 Suppl):14. PubMed ID: 1490841
    [No Abstract]   [Full Text] [Related]  

  • 10. [Alginate-containing preparation gaviscon for patients with gastroesophaginal reflux complicated with chronic pancreatitis: pathogenetic substantiation of clinical use prospects].
    Uspenskiĭ IuP; Pakhomova IG; Bubiakina VN
    Eksp Klin Gastroenterol; 2008; (1):96-101. PubMed ID: 19145860
    [No Abstract]   [Full Text] [Related]  

  • 11. The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants.
    Corvaglia L; Aceti A; Mariani E; De Giorgi M; Capretti MG; Faldella G
    Aliment Pharmacol Ther; 2011 Feb; 33(4):466-70. PubMed ID: 21158879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of action, efficacy, and onset dynamics of a single dose of alginates in patients with heartburn and GERD].
    Bordin DS; Masharova AA; Firsova LD; Kozhurina TS; Safonova OV
    Eksp Klin Gastroenterol; 2009; (4):77-85. PubMed ID: 19960998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gaviscon].
    Ménégol-Couque B; Brard M
    Soins; 1985 Jun; (455):I-II. PubMed ID: 2994235
    [No Abstract]   [Full Text] [Related]  

  • 14. [Failure of amiodarone in supraventricular tachycardia in an infant: drug interaction with Gaviscon(®)?].
    Chantepie A; Lefort B; Méot M; Jandali JC; Soulé N; Chantreuil J; Vaillant MC; Tisseron B
    Arch Pediatr; 2014 Jun; 21(6):663-4. PubMed ID: 24768351
    [No Abstract]   [Full Text] [Related]  

  • 15. Gaviscon bezoars.
    Sorbie AL; Symon DN; Stockdale EJ
    Arch Dis Child; 1984 Sep; 59(9):905-6. PubMed ID: 6091569
    [No Abstract]   [Full Text] [Related]  

  • 16. [Using gaviscon preparation for relief of esophageal, extraesophageal syndromes and functional dyspepsia in elderly patients with GERD].
    Onuchina EV; Brikova SI; Tsukanov VV
    Eksp Klin Gastroenterol; 2010; (10):80-6. PubMed ID: 21434379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment for resilient cough owing to laryngopharyngeal reflux with a combination of proton pump inhibitor and Gaviscon® Advance: how we do it.
    Lieder A; Issing W
    Clin Otolaryngol; 2011 Dec; 36(6):583-7. PubMed ID: 22212545
    [No Abstract]   [Full Text] [Related]  

  • 18. The mode of action and complications of Infant Gaviscon.
    Keipert JA
    Aust Paediatr J; 1979 Dec; 15(4):263-5. PubMed ID: 44677
    [No Abstract]   [Full Text] [Related]  

  • 19. [Gaviscon in reflux symptoms. Results of a drug monitoring study].
    Hutt HJ; Tauber O; Flach D
    Fortschr Med; 1990 Oct; 108(31):598-600. PubMed ID: 2258131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment with sodium alginate of gastroesophageal reflux disease in childhood: efficacy and tolerance assessment].
    Maestri L
    Pediatr Med Chir; 2001; 23(3-4):187-9. PubMed ID: 11723856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.